再次冠状动脉旁路移植术与初次手术的风险调整结局比较
该单中心回顾性研究纳入2009至2023年12120例初次CABG和341例再次CABG患者,采用风险评分匹配、逆概率加权和多变量调整分析。结果显示再次CABG的院内死亡率和10年生存率与初次CABG相似,但10年内再次血运重建风险显著更高。
要点
- 风险调整后再次CABG与初次CABG的院内死亡率无显著差异。
- 再次CABG术后10年内再次血运重建风险显著高于初次CABG。
- 两组10年生存率相当,主要围术期并发症相似。
核心结论
- 风险调整分析显示再次CABG的院内死亡率和10年生存率与初次CABG相似。
- 再次CABG术后10年内再次血运重建风险显著高于初次CABG。
研究设计与样本
- 单中心回顾性 review,纳入2009年1月至2023年12月所有孤立CABG手术。
- 排除急诊病例和数据缺失后,分析12120例初次CABG和341例再次CABG患者。
- 采用风险评分匹配、逆概率治疗加权和多变量调整方法评估结局。
主要发现
- 粗院内死亡率初次CABG为1.0%,再次CABG为1.8%。
- 风险评分匹配(258对)后,院内死亡率两组无统计学显著差异(1.2% vs 1.9%;相对风险1.68;95%CI 0.40-7.10)。
- 主要围术期并发症(卒中、心肌梗死、血液滤过、ECMO使用)相似,但再次CABG心肺复苏需求 tended higher。
- 逆概率加权敏感性分析院内死亡率初次CABG 1.0%、再次CABG 0.8%,相对风险0.75(95%CI 0.60-0.94)。
- 两组10年随访生存率相当,再次CABG再次血运重建显著更多。
临床怎么用
- 再次CABG在风险调整后院内死亡率和10年生存与初次CABG相当,可考虑用于复发或难治性缺血患者。
- 再次CABG术后需关注更高的再次血运重建风险,加强随访。
局限性
- 单中心回顾性设计可能限制普遍性。
- 排除急诊病例和数据缺失患者可能引入选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Coronary artery bypass grafting (CABG) is a mainstay of therapy for advanced coronary artery disease. The proportion of reoperative CABG has declined to ∼3% to 7% of all CABG procedures; however, redo operations remain essential for patients with recurrent or refractory ischemia. Redo CABG involves greater technical complexity and risk, highlighting the need for risk-adjusted analyses. METHODS: We conducted a single-center retrospective review of all isolated CABG procedures from January 2009 to December 2023. After excluding emergent cases and missing data, 12,120 first-time CABG and 341 redo-CABG patients were analyzed. We used risk-score matching, inverse probability of treatment weighting, and multivariable-adjusted approaches to assess in-hospital mortality, perioperative complications, and mortality and revascularization risks at up to 10 years of follow-up. RESULTS: Crude in-hospital mortality was 1.0% in CABG vs 1.8% in redo CABG. After risk-score matching (258 pairs), in-hospital mortality was not statistically significantly different between the 2 groups (1.2% vs 1.9%; relative risk, 1.68; 95% CI, 0.40-7.10). Major perioperative complications, including stroke, myocardial infarction, hemofiltration, and extracorporeal membrane oxygenation use, were similar. However, the need for cardiopulmonary resuscitation tended to be higher in redo CABG, and repeat revascularization at up to 10 years was significantly greater in redo CABG. Both groups demonstrated comparable survival at up to 10 years of follow-up. Sensitivity analysis using the inverse probability of treatment weighting approach resulted in in-hospital mortality rates of 1.0% (CABG) and 0.8% (redo CABG), with a relative risk of 0.75 (95% CI, 0.60-0.94). CONCLUSIONS: In this risk-adjusted analysis, redo CABG achieved similar in-hospital mortality and 10-year survival compared with CABG.
引用
- Radakovic D, Zittermann A, Braun CT, et al. Risk-Adjusted Outcomes of Reoperative vs Primary Coronary Artery Bypass Grafting. Ann Thorac Surg. 2025. PMID: 41456827. doi:10.1016/j.athoracsur.2025.12.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。